Inside Innovation

Seattle biotech company Cocrystal Pharma received permission from regulators to begin early-stage clinical trials for its COVID-19 and norovirus treatments. Previously, the company focused on

Access to Advanced Health Institute, a biotech nonprofit based in Seattle, received an $18 million grant from the National Institutes of Health. The funding will

Washington’s labor market has remained strong amidst national tech layoffs and indicators of a recession. According to the Bureau of Labor Statistics, high hiring rates

Phase Genomics, a Seattle-based biotech company, secured $2.5 million in funding from the National Cancer Institute and the Andy Hill Cancer Research Endowment (CARE) Fund

Seattle is ranked ninth in GEN’s 2023 rankings for the top 10 biopharma clusters across the country. Over the past year, major biotech moves including

Dexter Yard, a new, two-tower complex in Seattle, is becoming a home for several biotech companies moving into the space. Outpace Bio, Parse Biosciences and

Sana Biotechnology Inc., a biotech company based in Seattle, broke ground on its new Bothell manufacturing site recently. The 80,000 square-foot facility, which will provide

A report from Newmark announced that Cambridge, Massachusetts-headquartered pharmaceutical and biotech giant Moderna will support the Seattle’s market for office space by subleasing 54,350 square

Seattle-based biotech company Neoleukin Therapeutics announced that it will merge with Neurogene, a New York-based gene therapy organization. Finalization of the merger is expected to

A-Alpha Bio, a Seattle-based biotech company, raised $22.4 million to fund a machine learning project that will fuel its work to create therapeutic proteins. The

CBRE’s 2023 Scoring Tech Talent report declared Seattle as the second-best tech market in North America despite the industry’s ongoing layoffs. Seattle also ranked second